Elite Research Network

The Elite Research Network identifies clinical study opportunities by connecting our investigators with sponsors and contract research organizations. The group, comprised of independently owned, multi-specialty sites located throughout the United States, conducts clinical studies across a broad range of therapeutic areas in all clinical phases. By locating appropriate studies that match our sites’ capabilities and patient populations, our sites consistently meet or exceed enrollment goals. There is no additional cost to our clients and all contracts and study related payments are directly with the investigator sites. Sites within the network must meet and maintain certain entrance criteria. Each site has a dedicated research staff consisting of highly trained, board certified investigators, study coordinators, patient recruiters, and support staff. Sites have EDC capabilities, use central IRBs with start-up regulatory document turnaround time within 5 days or less, and are in full compliance with FDA, GCP, ICH, and IRB guidelines. Serving as a central point of contact for the network saves our clients time and resources by streamlining information to our sites in order to make informed decisions about which studies are most appropriate. This allows site identification, feasibility, and study start up to occur at an accelerated pace.

网站

https://www.eliteresearchnetwork.com

Elite Research Network的外部链接

所属行业

制药业

规模

2-10 人

总部

Mt. Pleasant，SOUTH CAROLINA

类型

私人持股

创立

2004

领域

investigator sites、vaccines、phase I、phase 1、phase II和phase III